comparemela.com

Latest Breaking News On - Insider activity at jazz pharmaceuticals - Page 6 : comparemela.com

Analysts Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Target Price at $200 75

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) has been given a consensus recommendation of “Moderate Buy” by the eight research firms that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month target […]

Assenagon Asset Management S A Raises Stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Assenagon Asset Management S.A. lifted its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 1,205.8% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 29,198 shares of the specialty pharmaceutical company’s stock after purchasing an additional 26,962 shares during the quarter. Assenagon Asset […]

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives Average Rating of Moderate Buy from Analysts

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) has received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year price target among brokerages […]

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives $200 75 Consensus Price Target from Brokerages

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Rating) has received a consensus recommendation of “Buy” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.